Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Sep 24 8-K 1 Endo Investor Presentation September 2024
- 29 Aug 24 424B3 Prospectus supplement
- 2024 Q2 10-Q Quarterly report
- 27 Aug 24 424B3 Prospectus supplement
- 27 Aug 24 8-K Endo Announces Ceo Transition
- 27 Aug 24 8-K Endo Reports Second-quarter 2024 Financial Results
-
1 Aug 24 EFFECT Notice of effectiveness
- 31 Jul 24 424B3 Prospectus supplement
- 26 Jul 24 S-1/A IPO registration (amended)
- 12 Jul 24 S-1 IPO registration
Filing view
External links
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | July 31, 2024 2:00 P.M. |
Form: | S-1 | ||||||
|